Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
Related Questions
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
How do you approach the "wearing off" phenomenon for patients with multiple sclerosis on B-cell-depleting therapies?
What are the possible or expected MRI findings or changes in progressive MS?
How do you decide between escalation to a high efficacy DMT versus switching to a different moderate efficacy DMT in patients with poorly controlled multiple sclerosis?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Would you consider anti-CD20 agents for treatment of multiple sclerosis in patients with history of breast cancer?
Do you see a current or future clinical role of neurofilament light chain in the diagnosis or workup of multiple sclerosis?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How do you use optical coherence tomography in the diagnosis and management of patients with multiple sclerosis and related diseases?
What baseline visual testing, if any, do you recommend at diagnosis for patients with multiple sclerosis who deny visual complaints?
